Encefalopatía asociada a Valproato / Val proate-associated hyperammonemic encephalopathy. Report of one case
Rev. méd. Chile
;
135(11): 1446-1449, nov. 2007. tab
Artigo
em Espanhol
| LILACS
| ID: lil-472844
ABSTRACT
Valproate can be associated to hyperammonemic encephalopathy, characterized by fluctuating sudden-onset alterations of sensorium, focal symptoms and an increase in the frequency of seizures. We report a 78 year-old female using valproate 1,000 mg/ day for 10 months for the treatment to tonic-clonic seizures. She was admitted on three occasions in the last fourth months for self limited clouding of sensorium. Laboratory, imaging and electroencephalografic studies were non-contributory Blood ammonia levels were 123 fig/dl (normal: 15-50 fig/dl). Due to the possibility of a hyperammonemic encephalopathy secondary to valproate, the drug was discontinued and she was treated with lactulose and intravenous L-carnitine, 1 g/day The patient showed a complete recovery within 48 hours. This drug-associated encephalopathy is a reversible but potentially fatal cause, probably underdiagnosed, that requires a high index of suspicion.
Texto completo:
DisponíveL
Índice:
LILACS (Américas)
Assunto principal:
Encefalopatias
/
Ácido Valproico
/
Hiperamonemia
/
Anticonvulsivantes
Tipo de estudo:
Estudo diagnóstico
/
Fatores de risco
Limite:
Idoso
/
Feminino
/
Humanos
Idioma:
Espanhol
Revista:
Rev. méd. Chile
Assunto da revista:
Medicina
Ano de publicação:
2007
Tipo de documento:
Artigo
País de afiliação:
Argentina
Instituição/País de afiliação:
Hospital Británico de Buenos Aires/AR
Similares
MEDLINE
...
LILACS
LIS